Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

NCT05538195 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
Colon Cancer
Rectal Cancer
Esophageal Cancer
Pancreatic Cancer

Interventions

BIOLOGICAL: CEA-targeted CAR-T cells
BIOLOGICAL: CEA-targeted CAR-T cells

Sponsor

Chongqing Precision Biotech Co., Ltd